Novo Nordisk's oral diabetes drug beats Jardiance in study
LONDON (Reuters) - An experimental diabetes pill from Novo Nordisk proved better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim's established Jardiance in a clinical study, the Danish drugmaker said on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Denmark Health | Diabetes | Empagliflozin | Endocrinology | Health | Jardiance | Study | Sugar